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and midbrain motivation circuits with sex
steroid signaling
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Kerim Mutig4, Luis M. Garcia-Segura5,6 and Lee E. Eiden2
Abstract
The lateral habenula (LHb) has a key role in integrating a variety of neural circuits associated with reward and aversive
behaviors. There is limited information about how the different cell types and neuronal circuits within the LHb
coordinate physiological and motivational states. Here, we report a cell type in the medial division of the LHb (LHbM)
in male rats that is distinguished by: (1) a molecular signature for GABAergic neurotransmission (Slc32a1/VGAT) and
estrogen receptor (Esr1/ERα) expression, at both mRNA and protein levels, as well as the mRNA for vesicular glutamate
transporter Slc17a6/VGLUT2, which we term the GABAergic estrogen-receptive neuron (GERN); (2) its axonal projection
patterns, identiﬁed by in vivo juxtacellular labeling, to both local LHb and to midbrain modulatory systems; and (3) its
somatic expression of receptors for vasopressin, serotonin and dopamine, and mRNA for orexin receptor 2. This cell
type is anatomically located to receive afferents from midbrain reward (dopamine and serotonin) and hypothalamic
water and energy homeostasis (vasopressin and orexin) circuits. These afferents shared the expression of estrogen
synthase (aromatase) and VGLUT2, both in their somata and axon terminals. We demonstrate dynamic changes in
LHbM VGAT+ cell density, dependent upon gonadal functional status, that closely correlate with motivational
behavior in response to predator and forced swim stressors. The ﬁndings suggest that the homeostasis and reward-
related glutamatergic convergent projecting pathways to LHbMC employ a localized neurosteroid signaling
mechanism via axonal expression of aromatase, to act as a switch for GERN excitation/inhibition output prevalence,
inﬂuencing depressive or motivated behavior.
Introduction
The habenulae are paired structures located at the
dorso-caudal part of the diencephalon and are typically
described as having medial and lateral subregions (MHb
and LHb). The LHb is notable for receiving inputs from
the basal ganglia and forebrain limbic system and pro-
jecting broadly to dopaminergic (DA) and serotonergic
(5-HT) neurons in the midbrain1–3. These midbrain
aminergic systems are widely recognized as key compo-
nents for reward and beneﬁt evaluation processing cir-
cuitries4–7. Recently, reciprocal inputs from midbrain
ventral tegmental area (VTA)8,9 and dorsal raphe nucleus
(DRN)10 have also been observed.
Experimental stimulation of the LHb inhibits midbrain
DA and 5-HT neuronal ﬁring (see refs.3,11,12). Behavio-
rally, global activation of LHb has been associated with
negative reward prediction error. That is, when an animal
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receives a reward that is less than expected or receives
aversive outcomes greater than expected, there is an
increased tendency of cells in the LHb to ﬁre, and the
individual will perceive the world in a systematically
negative way, as manifested by psychomotor deﬁ-
ciency6,13. In vivo electrophysiological recording in pri-
mates has provided an elegant demonstration of this
conclusion14.
Elevated deoxyglucose metabolism has been observed in
LHb across animal models of depression15. LHb lesion
results in reduced depressive behaviors and increased
dopamine and 5-HT turnover in the midbrain of rats
subjected to chronic stress16–18. Clinical ﬁndings have
shown abnormalities in habenula in depression19,20. Dis-
ruption of LHb ﬁring by deep brain stimulation (DBS)
produces remission of severe depression, while shutting
off DBS correlated with patient’s relapse, and re-
installation of DBS remitted depression again21. All of
these ﬁndings call attention to the LHb as a potential
locus for dysfunction in human neuropsychiatric disease,
including the negative symptoms of depression, particu-
larly if the intrinsic circuit-based functional connectivity
and modulatory mechanisms governing LHb synaptic and
circuit plasticity can be better understood.
The LHb contains widely and densely distributed vesi-
cular glutamate transporter 2- and 3- (VGluT2 and
VGluT3)-expressing glutamatergic neurons22,23 and many
of them also express membrane GABA transporters 1 and
4 (mGAT1 and mGAT4)24. There is also a prominent
presence of neuropeptides, especially in the medio-central
subdivision of the lateral habenula (LHbMC)25–34. A small
number of selectively distributed neurons in LHb express
typical GABAergic neuron markers GABA and GAD-65/
6734–36. Consistent with the notion of intrinsic
GABAergic neurons in LHb, a careful anatomical study
using Golgi–Kopsch silver impregnation method, done by
Iwahori 40 years ago, unambiguously identiﬁed a neuron
type “IV” as small cells with short axons, suggesting the
existence of a neural circuitry intrinsic to the LHb37.
However, the existence of functional GABAergic neurons
intrinsic to LHb is currently a topic of debate since a
complete description of GABAergic phenotype of a single
population of neurons in LHb, including the existence of
the GABA vesicular transporter VGAT, does not yet
exist38.
In addition to its neurotransmitter complexity the LHb
also features a rich expression, and selective localization,
of estrogen receptor-alpha (ERα)39,40, suggesting regula-
tion of LHb function by sex steroids. Sex steroid effects
reported have focused on female rat sexual receptivity and
maternal behavior40, however a recent paper reported that
in an ex vivo preparation, estradiol suppressed global
neuronal activities in the LHb region of male rats41.
Previously, we reported that the medial division of lat-
eral habenula (LHbM) in male rat hosts sparsely dis-
tributed GABAergic neurons that are particularly active
during response to homeostatic challenge. Local activa-
tion of these neurons is linked to suppression of global
LHb activity, suggesting that they are inhibitory within
LHb, and, potentially, functionally promote motivational
behavior34. In the current study, we adopted a combina-
torial approach to further investigate this intrinsic LHb
GABAergic system, its inputs and outputs, its dependence
on hormonal conditions and the consequences of in vivo
homeostatic manipulation of LHb synapses on modula-
tion of motivated behaviors in the rat.
Materials and methods
Animals
One hundred and ﬁfteen male Wistar rats from a local
animal breeding facility were used in this study. All pro-
cedures were approved by the Research and Ethics
Committee of the Faculty of Medicine, Universidad
Nacional Autónoma de México (IDs CIEFM-085-2013
and CIEFM-062-2016), in accordance with the principles
espoused in the Handbook for the Use of Animals in
Neuroscience Research (Society for Neuroscience.
Washington, DC 1991 and as updated periodically). Four
groups were employed: sexually active (SA, 300–500 g, b.
w., housed under standardized conditions, but each
housed with two females rats for three-day periods over a
period of 12 weeks with periodic harem changes; n= 20);
sexually inactive (SI, 300–450 g, housed with male rats,
three per cage, standard conditions of animal house, n=
100), gonadectomized rats, housed as for SI (Gnx, n= 40.
see section “Gonadectomy (Gnx) and hormone replace-
ment therapy (HRT)”) and Gnx treated with testosterone,
housed as for Gnx (Gnx-HRT, n= 10).
Chemicals
Chemicals and reagents were obtained from Sigma-
Aldrich, St. Louis, MO, USA, if not indicated otherwise.
Primary antibodies used in this study were against vaso-
pressin (rabbit anti-AVP, Peninsula-Bachem American,
Inc. USA, CA, T-4563, 1:4000), vasopressin (rabbit anti-
AVP, gift from R.M. Buijs42, 1:2000), tyrosine hydroxylase
(sheep anti-TH, EMD Millipore Corporation, MA, AB-
1542, 1:4000), serotonin transporter (goat anti-SerT,
Santa Cruz Biotechnology, CA, SC-1458, 1:2000), hypo-
cretin/orexin (rabbit anti-OR, gift from A. van del Pol43),
vesicular glutamate transporter 2 (guinea pig anti-
VGluT2, Frontier Institute, Co., Japan, gp-AF240-1,
1:1000), vesicular inhibitory amino acid transporter (rab-
bit anti-VGAT/VIAAT, provided by L. E. Eiden44, 1:1000),
GABA (mouse anti-GABA, Sigma-Aldrich Co. MO,
A0310, 1:1000), glutamic acid decarboxylase 65 kDa iso-
form (mouse anti-GAD-65, EMD Millipore Co. MA,
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MAB351, 1:2000), glutamic acid decarboxylase 67 kDa
isoform (mouse anti-GAD-67, EMD Millipore Co. MA,
MAB5406, 1:2000), parvalbumin (mouse anti-PV, Swant,
Switzerland, Cat. 235, 1:5000), P450 Aromatase (rabbit
anti-ARO, provided by L. M. García-Segura45, 1:2000),
P450 Aromatase (rabbit anti-ARO, Abcam, Cambrdge,
UK, AB18995, 1:2000), P450 Aromatase (mouse anti-
ARO, Acris, SM2222P, 1:200), estrogen receptor-alpha
(rabbit anti-ERα, Santa Cruz, CA, SC542, 1:2000),
androgen receptor (rabbit anti-AR, Santa Cruz, CA,
SC816, 1:2000), dopamine receptor 5 (rabbit anti-D5R,
also called D1Rb, Alomone, Israel, 1:1000), serotonin
receptor (mouse anti-5-HTR2a, BD pharmingen, Cat.
556326, 1:200), vasopressin receptor 1a (rabbit anti-V1a,
provided by K. Mutig and T. Giesecke, see SI method and
SI Fig. 3 for details), and green ﬂuorescent protein (mouse
anti-GFP, Abcam, Cambridge, UK, Ab291-50, 1:500). See
SI Table 1 for detailed information.
Juxtacellular labeling
For this study, juxtacellular recording and labeling was
performed in 48 male Wistar rats (300 g) according to
previous protocols33,34,46–48. The induction of anesthesia
was achieved using 4% v/v isoﬂurane (Soﬂoran Vet, Pisa,
Mexico) in O2 and maintained with urethane (1.3 g/kg, i.
p.; ethyl carbamate; Sigma) and supplemental doses of
ketamine (30 mg/kg, i.p.; Anesteket, Pisa, Mexico) and
xylazine (3 mg/kg, i.p.; Procin, Pisa, Mexico). Wound
margins were inﬁltrated with local anesthetic (lidocaine,
Pisa, Mexico). A stereotaxic frame (David Kopf Instru-
ments, CA) was used to ﬁx the animal in place and a
homeothermic heating device (Harvard Apparatus) was
used to maintain core temperature at 36 ± 0.5 °C. Cra-
niotomy was performed around the coordinates: −3.5 mm
posterior from Bregma and 0.5 mm lateral. See the sup-
plemental material for juxtacellular labeling procedure
details. After the procedure, the rats were maintained at
35 °C during 4–6 h before perfusion. Brain tissue was
subsequently processed as described in supplemental
material. Sections containing well-labeled somata,
revealed by streptavin-Alexa488 reaction, and with
observable axon-branching patterns indicative of biotin
diffusion at least beyond the cell soma were further pro-
cessed for VGAT/VGLUT2 immunoreaction and ERα
immunoﬂuoroscence reaction with corresponding sec-
ondary antibodies. Three neurons from three different
rats met inclusion criteria for this study, which included
visualization of axon-like branching within the LHb,
allowing for their post-hoc molecular and morphological
characterization. Exclusion criteria included limited
labeling, multiple cell labeling, lack of internally branched
proﬁles, or anatomical localization outside of LHbM. For
more details, see the SI Experimental Procedures.
Immunohistochemistry
Immunohistochemistry was carried out using a stan-
dard free-ﬂoating method as described previously34.
Unless speciﬁed otherwise, we used SA rats (300–400 g, b.
w., N= 5) for IHC. In the experiments where the effect of
gonadal steroids was evaluated, we used Gnx and Gnx-
HRT rats. See SI Table 1 for detailed primary antibody
information.
Fluoro-gold retrograde tracing
Fluoro-gold retrograde tracing was performed accord-
ing to previously published protocols49. Ten male Wistar
rats (b.w. 300 g) were used. See SI Experimental
Procedures.
RNAscope In Situ Hybridization (ISH) assays
The ISH probes for rat Slc32a1(mRNA encoding
VGAT), Slc32a1-C3 (mRNA encoding VGAT in channel
2), Slc17a6 (mRNA encoding VGLUT2), Slc17a6-C2
(mRNA encoding VGLUT2 in channel 2), Gad1 (mRNA
encoding GAD-67), Gad2 (mRNA encoding GAD-65),
Esr1 (mRNA encoding ERα), Hcrtr2 (mRNA encoding
orexin receptor 2) were designed and provided by
Advanced Cell Diagnostics (Hayward, CA). All steps were
performed following RNAscope protocols for RNAscope
Fluorescent Multiplex Assay, 2.5 HD, Duplex Assay and
2.5 HD Assay-Brown for rat brain fresh frozen tissue. For
VGAT mRNA (Slc32a1) expressing neuron density
assessment, we cryosectioned four brains per group (N=
16) and kept ﬁve series (A–E) of habenula per sample.
Sections (12 μm thick) located at the same position of
each series were continued sections. Hence, one series per
each brain was ﬁxed and stained with hematoxylin and
served as anatomical reference for ISH section selection.
Sections containing two habenulae (left and right as
habenular asymmetry has been recognized50,51) around
Br. −3.72 mm from four rats (n= 8) were used. Complete
experimental methods are described in SI Experimental
Procedures.
Gonadectomy (Gnx) and hormone replacement therapy
(HRT)
Juvenile male rats of post-natal day 35 were used (N=
40). Under anesthesia with ketamine (100 mg/kg, IP) and
xylazine (10 mg/kg, IP, Procin, Pisa, Mexico), a small
surgical incision was made in the center of the scrotum.
The testicles and spermatic cord were exposed through
the surgical wound, then the spermatic cord was cauter-
ized and the testicles removed. The incision was closed
with nylon 3-0 sutures and rats treated with ketorolac and
ceftriaxone during the post-operative period.
For HRT, after 60 days of Gnx, 10 subjects received
monthly s.c. injections of Sustanon (dose: 250 mg/kg body
weight). Sustanon 250 is a long-acting mixture of
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Fig. 1 (See legend on next page.)
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testosterone esters: testosterone propionate (20%), tes-
tosterone phenylpropionate (40%), and testosterone iso-
caproate (40%) (Organon Mexicana, CdMx, Mexico). Rats
were housed two per cage. See SI Experimental Proce-
dures for further details.
Live cat exposure, forced swimming test, and behavioral
scoring
The experiments were performed according to a pre-
viously published protocol34 (n= 10). See SI Experimental
Procedures.
Data analysis
Quantitative results were expressed as mean ± SEM.
Groups were tested for normality with a D’Agostino and
Pearson’s test. Differences between paired groups were
calculated by Student’s two-tailed t-test. Multiple group
comparisons were performed using Bonferroni post hoc
test after ordinary one-way analysis of variance (ANOVA),
speciﬁed in the “Result” section for each experiment.
Post-hoc differences were considered statistically sig-
niﬁcant at a value p < 0.05 (*p < 0.05, **p < 0.01, ***p <
0.001).
Results
The LHbMC hosts a cell type expressing nuclear ERα and
VGAT at axon terminals, with dual local circuit and long-
range projection patterns
We previously described the existence of three in vivo
juxtacellularly labeled GABA/GAD-positive neurons in
LHbMC34. In this study, we sought a more complete
characterization of this cell type via identiﬁcation and
reconstruction after in vivo juxtacellular labeling. Three
more cells were successfully labeled and internally bran-
ched axons and axon terminal (ATs) were ﬁlled with
Neurobiotin (Fig. 1; SI Figs. 1 and 2). We found that all
three labeled neurons expressed nuclear immunor-
eactivity for ERα (Fig. 1a, A1 and b, B1; SI Fig. C1), with
their ATs immunopositive for VGAT (Fig. 1a, A6–A7 and
b, B4; SI Fig. 1, C6), but not for VGLUT2 (data not
shown).
All these neurons had local as well as long-range axonal
collaterals. Indeed, for one cell, the labeled axon was
traced to the midbrain at which point one branch crossed
the midline and branched inside the substantia nigra pars
reticulata (SNpr), with axon terminals making appositions
onto parvalbumin IR somata and dendrites (SI Fig. 2).
Note that additional branches of this neuron into more
caudal extensions of fasciculus retroﬂexus (fr) may exist,
with Neurobiotin visualization impeded by white matter
of this conduction system52,53. This conﬁrms the presence
of an LHb GABAergic cell type distinguished by expres-
sion of ERα and a likely a role both within the LHb and at
midbrain centers. In the following we call these
GABAergic estrogen-receptive neurons (GERNs) for
convenience of referral.
High-resolution anatomical and molecular interrogation of
LHbM GERNs
The population which selectively expressed ERα-IR was
restricted to speciﬁc anatomical coordinates of within the
LHbM (Fig. 2a): we did not detect ERα-positive cells in
Fig. 1 A novel type of GABAergic neuron with bi-functional output, was identiﬁed using in vivo juxtacellular single-cell labeling,
immunostaining, and anatomical reconstruction methods. Three cells are reported in this study, one per each nucleus of the medial division of
the lateral habenula (the superior, LHbMS, the central, LHbMC, and the marginal, LHbMMg) are depicted in one schematic coronal view of the
habenula aiming to give a general idea about their spatial relationship with the region and among them, although they were from three different
rats. Camera-lucida reconstruction from serial sections of the neuronal somata, dendrites, and axons were superimposed manually in a 2-dimension
(2D) projection drawing from a coronal view of the rat habenula. The soma and dendrites were represented in black and axonal segments were
color-coded as blue for cell A (located in the LHbMS), and green for cell B (located in the LHbMC) (see the third cell in SI Fig. 1). A1: The soma of the
cell A is immunopositive to ERα. A2, A3: photomicrographs of labeled soma and proximal dendrites revealed by avidin-biotin-peroxidase
diaminobenzidine reaction, at low and high magniﬁcations, red arrowhead in A3 shows the emergence site of the main axon. A4: photomicrograph
of a rare axonal terminal-like arborization observed at the squared region in the reconstruction. A5: the main axon emitted a single collateral that
coursed ventrally and branched in the medial central region of the LHb (the branching point is indicated by an asterisk, also shown in the inset and in
the reconstruction). Note in the reconstruction that the projecting axon entered to the fr and was found in further caudal sections. A6, A7:
neurobiotin/VGAT double labeling at axon terminals (white solid arrows). Note that some neurobiotin-labeled axonal VGAT (hollow white arrows). A8:
upper traces. extracellular recording of low spontaneous ﬁring pattern and lower trace shows that when low intensity (<10 nA) positive current
pulses were injected by way of the microelectrode, the neuron ﬁring pattern was modulated, a requirement to yield a successful labeling. Scale bars:
A1: 25 µm; A2: 500 µm; A3: 50 µm; A5: 100 µm; A7, A8: 10 µm. B1: Immunohistochemical detection of ERα expressed in the neurobiotin-labeled cell. B2: a
compound photomicrograph made up by photomicrographs taken from 11 consecutive sections showing the neurobiotin-labeled soma and the
main axon projecting to the fr. In a proximal point of the main axon, an axon-collateral was emitted (indicated by a red asterisk and a circle). Inset
shows a higher magniﬁcation photomicrograph of the collateral origin point. B3: shows the intrahabenular branched axon segments and ATs labeled
with neurobiotin (NB). B4: confocal images show the GABAergic nature of this cell (ATs immunopositive to VGAT). B5: Axon terminals found in caudal
sections at the level of sustantia nigra pars reticulata, in close apposition with parvalbumin-expressing dendrites. B6: upper traces are extracellular
recording of spontaneous ﬁring patterns (7.3 Hz before electrical modulation applied for juxtacellular labeling purpose, lower trace). Scale bars: 20 µm
except B3: 100 µm and B5: 10 µm
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either rostral or caudal portions of LHb (Fig. 2a, A1 and
A8). With RNAscope ISH we found that neurons in the
LMbMC co-expressed mRNA for ERα (Fig. 2b, B1, red
punctate labeling) and Slc32a1, mRNA encoding VGAT
(green punctate labeling, arrows indicate double-labeled
cells), as well as Slc17a6, encoding VGLUT2 (Fig. 2b, B2,
green punctate labeling for Slc17a6; arrows indicate
double-labeled cells). Unexpectedly, every single Slc32a1-
positive neuron was also positive for Slc17a6 (Fig. 2b).
Fig. 2 (See legend on next page.)
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The Slc32a1 signal was restricted to the central medial
nucleus LHbMC of rat lateral habenula (circumscribed
region of Fig. 2 upper inset of panel B3, RNAscope
chromogenic-Brown method). At the immunohisto-
chemical level, the majority (68%) of GABA-expressing
neurons were immunopositive for ERα (Fig. 2c). Fur-
thermore, these Esr1+/Slc32a1+ cells also co-expressed
Hcrtr2 (mRNA enconding hypocretin/orexin receptor 2)
(Fig. 2d, D1), and were immunopositive for V1aR (Fig. 2d,
D2), for HTR2A (Fig. 2d, D3), and for D5R (Fig. 2d, D4).
Projections containing AVP, orexin, dopamine, and
serotonin to LHbM exhibited a common molecular
signature of aromatase and VGLUT2 expression
We have identiﬁed LHbM as a prime region of con-
vergent input of hypothalamic vasopressin (AVP) and
orexin, and midbrain dopamine and serotonin systems by
immunohistochemistry in combination with ﬂuoro-gold
retrograde tracing (SI Figs. 4 and 5). In light of the
selective location of GERNs in the LHbM, and the
apparent absence of estrogen synthetic capacity by cells of
LHb, we asked whether the pre-synaptic inputs to these
cells might produce estrogen. Using IHC and confocal
microcopy we found that the four types of inputs to
LHbMC were immunopositive for VGLUT2 and aroma-
tase (Fig. 3a–d). The hypothalamic vasopressinergic
paraventricular, supraoptic and suprachiasmatic nuclei
(PVN, SON, and SCN, respectively) and orexinergic lat-
eral hypothalamic area (LH) were identiﬁed as hypotha-
lamic inputs to LHbM, as were the dopaminergic
substantia nigra (SN) and ventral tegmental area (VTA),
and the serotonergic dorsal raphe lateral (DRL) nucleus,
as the midbrain inputs to LHbM (SI Fig. 5B–D). Results
pertaining to aminergic and peptidergic projections to
LHbM are summarized diagrammatically in Fig. 3e. The
clear demonstration of these inputs to the LHbM is
consistent with the current literature (see a recent
review36) but does not exclude convergence of other types
of projections to the LHbM.
Hypothalamic peptidergic and midbrain aminergic inputs
to LHbM with a shared sex steroid-responsive phenotype
We performed immunoﬂuorescence experiments to
evaluate the co-localization of androgen receptor (AR)
and aromatase (ARO) in cells of hypothalamic AVP+ and
OR+ nuclei and in midbrain cells of SerT+ and TH+
nuclei. Most of the amine-positive or peptide-positive
neuronal nuclei were also immunopositive for AR, with a
smaller but substantial number displaying aromatase-
positive cytoplasm (Fig. 4).
Regulation of midbrain to GERN and hypothalamo to GERN
circuits, and aversive behavioral responses, by hormonal
status
To assess involvement of testosterone in these circuits,
we employed two sets of experimental conditions. GERN
afferents were compared in intact and gonadectomized
(Gnx) males. Gonadectomy produced a remarkable
reduction of AVP-IR in the SON and PVN nuclei (SI Fig.
6A–F), as well as a reduction in the percentage of aro-
matase/AVP double-labeled cells (SI Fig. 6G). In addition,
AVP-IR ﬁbers almost disappeared completely in the
LHbM (Fig. 5a, A1 vs A2). Our results are in accordance
with previous studies showing AVP system hypofunction
as a result of decreased gonadal steroid levels54,55. Thirty
days after the onset of testosterone replacement therapy
(HRT) (PGnxD60+ HRT30), the AVP-labeling pattern
was restored (Fig. 5a, A3). The orexinergic, dopaminergic,
Fig. 2 GABAergic estrogen-receptive neurons (GERNs) localization, mRNA expression by ISH and somatic receptor expression by IHC. a
Serial coronal sections showing the ERα immunolabelling at the Bregma rostro-caudal coordinates (numbers in mm under the photomicrographs).
Boxed area in A6 at higher magniﬁcation showing the exclusive nuclear labeling pattern. The bold numbered levels (A1 and A8), were chosen to show
that no positive labeling was found in either rostral or caudal directions. A9: a horizontal view of the distribution of estrogen-receptive cells was
symbolized by the red oval. A10: sagittal view of rat brain atlas, modiﬁed from Paxinos & Watson
86, at lat. 0.90 mm, where lateral habenula (LHb) is
symbolized with a gray shade and A9 plane was symbolized with a horizontal line. b In situ hybridization using multiple RNAscope methods. B1:
multiplex ﬂuorescence method, Esr1, gene that encodes ERα (red punctuated labeling) co-expressed with Slc32a1, gene that encodes VGAT (green
punctuated labeling); arrows indicate the double-labeled cells; B2: duplex method, Esr1 (red punctuated labeling) co-localization with Slc17a6, gene
that encodes VGLUT2 (green punctuated labeling); arrows indicate the double-labeled cells; B3: with duplex method, Slc32a1 encoding VGAT (red
punctuated labeling) shows complete co-localization with Slc17a6 encoding VGLUT2 (green punctuated labeling); arrows indicate the double-
labeled cells. Inset of B3, Slc32a1 expression in a sexually active (SA) rat LHb, Br. −3.72 mm (brown labeling, single chromogenic-Brown method-
RNAscope). *Note the similarity with ERα expression in A6. c Indirect immunohistochemistry showing the GABAergic nature of the ERα+ neurons
(red) in a SA rat brain. The GABA antibody (green, Sigma, A0310) produced characteristic surface labeling (C1, C2: the strip-like image was produced by
Vibratome slicing leaving the brain section with an uneven surface). d ERα+ neurons co-express receptor/receptor subtypes for vasopressin, orexin,
dopamine, and serotonin. D1: In situ hybridization using RNAscope-multiplex method targeting Esr1 (red dots), Slc32a1 (white dots) and Hcrtr2, gene
encodes the orexin receptor 2 (green dots). D2, D3: Indirect immunoﬂuorescence reactions, showing that the ERα-IR cells co-expressed vasopressin
receptor V1a (inset showing the V1a antibody labeling pattern in temporal hippocampus CA2 cells body layer. See also SI Fig. 6 for more information
about this antibody), dopamine receptor D5R (also called D1Rb) and serotonin receptor 5-HTr2a, respectively. Scale bars: A5 and b: 500 µm and rest:
10 µm
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Fig. 3 Presence of convergent inputs from vasopressinergic, orexinergic, dopaminergic and serotoninergic pathways expressing VGluT2
and P450 aromatase in LHbM where the GERNs cells were located. a–d Confocal images revealed that axon terminals immunopositive for
neurophysin II (NPII, a), orexin (OR, b), serotonin transporter (SerT, c), and tyrosine hydroxylase (TH, d) contained aromatase (ARO) and vesicular
glutamate transporter 2 (VGLUT2) inside the LHbMC. Note in c, 3D computer reconstruction of the serial optical slices in Z-stack to show that ﬁbers
which expressed SerT were of two types: thick SerT+/VGLUT2+/aromatase+ (yellow arrows) and thin SerT+/VGLUT2−/aromatase− proﬁles (green
arrows). Insets for each confocal photomicrograph group show the global ﬁber distribution patterns with peroxidase immunoreaction against
arginine vasopressin (AVP, a), orexin (OR, b), serotonin transporter (SerT, c), and tyrosine hydroxylase (TH, d) at the LHbM region. A detailed
anatomical distribution from serial coronal sections is depicted in SI Fig. 3. e Summary diagram of FG retrograde tracing results presented in SI Fig. 4.
The upstream regions identiﬁed by FG retrograde tracing experiments are coded by colors: hypothalamic vasopressinergic nuclei in blue; lateral
hypothalamic orexinergic cell population in gray; dorsal raphe lateral (DRL) serotonin transporter (SerT) expressing neurons in beige; substantia nigra
pars compact (SNpc), and ventral tegmental area (VTA) tyrosine hydroxylase (TH) expressing neurons in pink. The projection distributions of each
pathway, in the habenula region, are symbolized with the corresponding color patches. The beige gradient ﬁlling symbolizes the predominant
distribution pattern of SerT+ ﬁbers observed (for details see SI Fig. 3D). The four pathways to habenula (color-coded arrows) shared a common
feature of co-expression of VGLUT2 (symbolized in green) and estrogen synthase/P450 aromatase (symbolized in red). Scale bars: a–d 500 µm and e–
h 10 µm
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and serotoninergic systems, however, were not noticeably
affected by gonadectomy (data not shown), albeit fully
processed orexin-, and DA- and 5-HT-positive terminals
themselves, were not directly assessed in our experiments.
In a second set of experiments, the effects of hormonal
conditions on the Slc32a1-positive cell density in LHbMC
was examined using RNAscope methods. Sexual activity
was also examined as a variable, since sexual activity with
unfamiliar female subjects has been shown to increase the
levels of testosterone in males56,57. We found signiﬁcant
differences between groups in the number of Slc32a1+
neurons. (one-way ANOVA ***p= 0.0003). The number
of Slc32a1-positive cells in LHbMC was signiﬁcantly
greater in SA compared to SI male rats (*p < 0.05), and
Slc32a1 expression was also markedly increased by HRT
in gonadectomized male rats (**p < 0.01, Fig. 5b). The
effect of hormone replacement therapy (HRT, for 30 days
in Gnx male rats), or sexual activity, on the number of
Slc32a1- or Esr1-expressing neurons in the LHbM was
quantiﬁed (Fig. 5b, B1 and B2). HRT and sexual activity
signiﬁcantly increased the number of Slc32a1 neurons in
LHbM, with no signiﬁcant differences found between SI
and Gnx rats. With respect to the Esr1 expression after
Gnx, HRT, or sexual activity, no signiﬁcant differences
were found.
Finally, we investigated possible implications of the
above mentioned manipulation on depressive vs motiva-
tional behaviors in two simple tests, placing the rats in
psychological and physical life-threatening conditions: (i)
assessing the innate fear processing using the exposure to
a live cat34,58, and (ii) assessing behavioral despair using a
modiﬁed version of the forced swim test (FST)59,60.
Negative and positive motivational valence representa-
tions were correlated with freezing vs. rearing/climbing/
displacement during cat exposure and immobility vs
climbing during FST. As the major neurochemical effects
of manipulation of testosterone levels was on GERNs
themselves, and on pre-synaptic vasopressinergic inputs
to the LHb, and as we have previously observed that
osmotic hypothalamic magnocellular AVP upregulation
Fig. 4 Androgen receptor (AR) and P450 aromatase (ARO) expression in PVN, LH, VTA/SNpc and DRL, AVP+, OR+, TH+ and SerT+
neurons, respectively. The series of a–d show the confocal images for co-expression of AR, aromatase and AVP (PVN, a), orexin (LH, b), SerT (DR, c)
and TH (VTA, d). Examples of co-expressed cells are indicated with arrows. Scale bars: a 500 µm; A1–A4: 50 µm; b 500 µm; B1–B4: 20 µm; c 500 µm;
C1–C4 25 µm; d 1 mm; D1–D4 50 µm
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suppressed the LHb functional output and promoted
escape behaviors during predator exposure and behavioral
despair test (FST), we evaluated intact undisturbed rats,
relative to rats with water and food deprivation for 24 h
(WFD). These conditions were compared with gona-
dectomized (Gnx) rats, and Gnx+HRT rats.
Fig. 5 (See legend on next page.)
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The effects of Gnx on the passive stress coping strate-
gies (freezing) or active stress coping strategies (rearing/
climbing/displacement), displayed when exposed to a live
predator, are shown in Fig. 5c. The Gnx group showed an
increase (52.54 ± 7.092 vs control 28.33 ± 3.145 counts, n
= 6, p < 0.05) in the passive (freezing, grooming) behavior
and a decrease (47.46 ± 7.092 counts vs control: 71.67 ±
7.600 counts, p < 0.05) in active escape (climbing, rearing,
displacement, orientation) behaviors.
The effect of Gnx combined with hormone replacement
therapy (HRT) or water and food deprivation (WFD) on
behavioral despair was quantiﬁed as the number of
immobility episodes in the forced swimming test (FST)
(Fig. 5d). Differences between means were found statis-
tically signiﬁcant by one-way ANOVA (F(3, 23)= 44, ***p
< 0.0001). Gnx signiﬁcantly increased the immobility
counts in the FST (33+ 1.8 vs. 65+ 3.8 counts in control
and GNX, respectively, ***p < 0.001), whereas castrated
(Gnx) rats that received HRT recovered to levels com-
parable to control animals (control: 33+ 1.8 counts vs.
HRT: 25+ 4.7 counts, p > 0.05). Water and food depri-
vation, in turn, signiﬁcantly decreased the immobility
counts relative to control.
Discussion
Enhanced excitatory input to LHb is generally asso-
ciated with global activation of this nucleus, leading to
inhibition of the connected midbrain monoaminergic
systems, driving aversion and psychomotor deﬁciency6.
This dogma has been supported by extensive studied
using a variety of experimental strategies, including short-
term circuit manipulation techniques61,62. However, here,
by studying the mid-term and long-term hormones
inﬂuences on LHb circuitry organization and the sub-
sequent behavioral modiﬁcations, in male rats, we
obtained data that challenge the completeness of the
above notion.
Previously, we established the existence of GABAergic
interneurons inside the LHb. Here, we show key proper-
ties of these same neurons, using the linking technology of
juxtacellular labeling in vivo, and the use of a new anti-
body against the vesicular GABA transporter (VGAT)
that unambiguously identify these cells as GABAergic (as
GAD is no longer considered such a deﬁnitive marker for
functionally GABAergic cells), we identify them as rele-
vant to peptidergic/neurosteroid synaptic transmission
with implications to gonadal/neurosteroid modulation of
behavior. The projection axons of these GERN cells enter
the fasciculus retroﬂexus and at least one cell sent pro-
jections to the region of the tail of VTA (RMTg) and the
medial part of substantial nigra pars reticulata, making
close contact to parvalbumin positive neurons. These
characteristics establish the potential novelty and impor-
tance of GERN cells in LHb circuitry, and we then set out
to identify the impingents upon these cells, and their
potential role in homeostatic and hormonal/sex steroid
modulation of motivated behavior.
In this study, using complementary molecular, electro-
physiological, anatomical, hormone status manipulation,
and behavioral approaches, we have identiﬁed four glu-
tamatergic inputs to the LHbM from hypothalamic water
and energy homeostasis and midbrain reward/value eva-
luation circuits, containing vasopressin, orexin, dopamine,
and serotonin, respectively, where a discrete estrogen-
receptive cell population expressing molecular signatures
for both GABA and glutamate neurotransmission were
located. Juxtacellularly labeled single VGAT+/ERa+ cells
within this region emitted main axons joining the fasci-
culus retroﬂexus, as well as locally branching collaterals.
Single-labeled neurons lacked light-microscopically
visualizable VGLUT2 terminal immunoreactivity, sug-
gesting that their functional neurotransmitter phenotype
is likely inhibitory.
Although there have been recent intriguing discoveries
that detail glutamate to GABA transmitter switching in
habenular inputs63, the GABAergic microcircuit intrinsic
to the habenula has remained enigmatic. Early morpho-
logical studies suggested the existence of interneurons37,
and GAD activity was only reduced 40% in stria
medullaris-lesioned rat, indicating the existence of a
Fig. 5 Hormonal conditions affect GERN-LHbM input composition and cell density: correlation with depressive vs motivated behaviors. a
Gonadectomy in male rats produced a remarkable reduction of AVP immunoreactivity in lateral habenula medial (LHbM) that is restored with
hormone (testosterone) replacement therapy (HRT). A1: Control; A2: AVP-IHC performed 60 days after gonadectomy (PGnxD60), and A3: 60 days after
gonadectomy animals received hormone replacement therapy for 30 days (PGnxD60+HRT30). b Photomicrographs showing in situ hybridization
experiment using RNAscope 2.5 HD Assay-BROWN method. B1: Slc32a1 cell density changed in the LHbM under the four hormonal conditions. HRT
(**p < 0.01) and sexual activity (*p < 0.05) signiﬁcantly increased the number of Slc32a1 neurons in LHbM. B2: No signiﬁcant differences were found
between all groups SI and GNX rats with respect to the Esr1 expression. c Upon cat exposure, rats expressed innate fear-related passive (freezing), and
active (rearing, climbing, and displacement) behaviors: rats from 60 days post gonadectomy group (Gnx) showed signiﬁcant increase of freezing
counts (*p= 0.0203) and reduced number of climbing and rearing behaviors (*p= 0.0421). d Quantiﬁcation of behavioral despair assessed using
forced swimming test (FST). Gnx signiﬁcantly increased the immobility counts in the FST (***p < 0.001). Gnx rats that received HRT recovered to levels
comparable to control animals. By contrast, water and food deprivation had the opposite effect, signiﬁcantly decreasing the immobility counts
compared to control (*p < 0.05)
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source of GABA intrinsic to the habenula64. However,
evidence for phenotypically patent (i.e., VGAT-positive)
GABAergic neurons in this region has been incomplete38.
This GABAergic neuron population in LHb, as char-
acterized here, is dynamically regulated by gonadal func-
tional status, as evidenced by rather pronounced
alteration in VGAT mRNA-positive cell density upon
castration, and reversal by hormone replacement therapy.
The regiospeciﬁcity of this effect appears to derive from
local conversion of testosterone to estrogen, contributed
by convergent aromatase-expressing excitatory inputs to
LHbM, also containing neuropeptides or monoamines.
The enzyme aromatase catalyzes the transformation of
the androgen testosterone to estrogen. Here, we found
aromatase distributed to glutamatergic axon terminals,
together with neuropeptides and monoamines. Aromatase
activity in these projections may also to be regulated by
testosterone levels via AR and to synthesize estradiol. The
presence of aromatase at pre-synaptic terminals, allowing
highly localized production of estradiol, has been
demonstrated at the electron microscope level65. Estrogen
exerts a synergistic effect on glutamatergic synapses in
hippocampus both pre-synaptically and post-
synaptically66; and estrogen is known to facilitate neuro-
peptide release67. These ﬁndings support the organizing
actions of androgens as previously suggested68,69.
To explore the sex steroid responsivity of these inputs,
and of their cell targets in the LHbM, we focused on the
well-characterized vasopressinergic input from hypotha-
lamus, the expression of VGAT and ERα in the GERNs
themselves, and modulation of motor responses following
application of aversive stimuli. Gnx induced a decrease in
AVP/aromatase/VGLUT2-positive ﬁbers and in the den-
sity of neurons expressing the GERN phenotype in the
LHb, and concomitantly, decreased escape behavior dur-
ing FST and predator exposure tests. HRT restored VP
input to LHb, increased the density of cells exhibiting the
GERN phenotype in LHb, and restored the propensity for
active escape behaviors in both tests. Consistent with
these results, GERN cell density was signiﬁcantly higher in
SA male rats, and consequently higher testosterone levels,
than SI male rats.
There is evidence that estradiol has enhancing and
trophic effects on GABAergic circuits. It has been shown
that locally produced, aromatase-dependent, estradiol
levels positively correlate with GAD-65 synthesis, thereby
supporting GABAergic neurotransmission in cultured
neurons70. Estrogen has been shown to enhance excita-
tory neurotransmission by upregulating the expression of
glutamate receptors71. On the other hand, deletion of ERα
expression in GABAergic, but not glutamatergic hippo-
campal neurons has a pronounced effect on estrogen-
dependent behavioral masculinization in the mouse72.
Moreover, estradiol enhances the release probability of
dense core vesicles73, which could provide a mechanism
of increased excitability due to convergent projections of
OR, AVP, DA, and 5-HT.
Neuropeptides have been shown to increase the ﬂex-
ibility of neural circuits by switching the inhibitory/exci-
tatory properties of neural circuits. For instance, it has
been demonstrated in C. elegans that the neuropeptide
INS-6, released in response to large changes in salt con-
centrations, increase the ﬂexibility of neural circuits, by
functionally transforming a sensory neuron in the neural
circuit for high salt into a GABAergic interneuron74. Also
in development, an increase in neural activity per se has
been demonstrated to induce a phenotype change from
glutamatergic to GABAergic75 or in the adult rat hypo-
thalamus, between expression of dopamine or somatos-
tatin in response to short or long photoperiods76. Change
in neurotransmitters expressed by circuits involved in
sensorimotor processes appear to be a common phe-
nomenon by which neural activity, gonadal status or
peptidergic neuromodulation combine their actions to
ﬁne-tune behavior. The presence of aromatase in the
projections onto the lateral habenula, together with the
demonstration of estrogen sensitivity in this subpopula-
tion of locally branching GABAergic neurons, support an
increased functional inhibition of the habenula depending
on diverse neuroendocrine status.
Thus, the GERN of the LHbM, together with their
peptidergic and aminergic inputs, represent a node at
which several evolutionarily well-conserved motifs—
homeostatically sensitive peptide modulation77–79, ami-
nergic reward pathways4,80, co-regulation of sex steroid
synthesis and responsivity81–83, and circuit placement that
guarantees propagation of peptide, amine, and sex steroid
modulation of behavior—all converge.
The physiological state of a network and its level of
activity can have a profound effect on neuromodulatory
actions on postsynaptic cellular plasticity changes84. Our
ﬁndings provide a concrete example of GABAergic phe-
notypic switching85 and its maintenance as a long-term
integrator of inputs from homeostatic and reward-
controlling pathways. Modulation of synaptic function
within this circuit may be importantly regulated by local
(synaptic) conversion of the gonadal steroid testosterone
to estrogen via aromatase contained in nerve terminals
impingent upon this LHbMC GABAergic cell population.
Acknowledgements
This work was supported by DGAPA-UNAM-PAPIIT-IN216214, CONACYT-CB-
176919 & CB238744 (to L.Z.) and NIMH-IRP-1ZIAMH002386 (to L.E.E.). L.Z. is a
Fulbright visiting scholar, also supported by PASPA-DGAPA-UNAM fellowships
for her sabbatical leave. We are thankful to Anthony van del Pol for gift of anti-
orexin antibody; to Carolyn Smith and Vincent Scharam for assistance with
confocal microscope; to Enrique Pinzon for animal facility assistance; to
Joseﬁna Maus for help with antibody acquisition and to Miles Herkenham,
Peter Somogyi, Carmen Sandi, Okihide Hikosaka, and Hyunchan Lee for critical
reading and comments on an earlier version of the manuscript.
Zhang et al. Translational Psychiatry  (2018) 8:50 Page 12 of 14
Author details
1Departmento de Fisiología, Facultad de Medicina, Universidad Nacional
Autónoma de México, Mexico City, Mexico. 2Section on Molecular
Neuroscience, National Institute of Mental Health (NIH), Bethesda, USA.
3Institute for Biomedical and Biomolecular Sciences, School of Pharmacy &
Biomedical Sciences, University of Portsmouth, Portsmouth, UK. 4Department
of Anatomy, Charité-Universitätsmedizin Berlin, Berlin, Germany. 5Instituto
Cajal, C.S.I.C., Madrid, Spain. 6CIBERFES, Instituto de Salud Carlos III Madrid,
Spain
Conﬂict of interest
The authors declare that they have no conﬂict of interest.
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Supplementary Information accompanies this paper at https://doi.org/
10.1038/s41398-018-0099-5.
Received: 24 December 2017 Accepted: 8 January 2018
References
1. Herkenham, M. & Nauta, W. J. Afferent connections of the habenular nuclei in
the rat. A horseradish peroxidase study, with a note on the ﬁber-of-passage
problem. J. Comp. Neurol. 173, 123–146 (1977).
2. Herkenham, M. & Nauta, W. J. Efferent connections of the habenular nuclei in
the rat. J. Comp. Neurol. 187, 19–47 (1979).
3. Christoph, G. R., Leonzio, R. J. & Wilcox, K. S. Stimulation of the lateral habenula
inhibits dopamine-containing neurons in the substantia nigra and ventral
tegmental area of the rat. J. Neurosci. 6, 613–619 (1986).
4. Wise, R. A. Dopamine, learning and motivation. Nat. Rev. Neurosci. 5, 483–494
(2004).
5. Schultz, W. Behavioral theories and the neurophysiology of reward. Annu. Rev.
Psychol. 57, 87–115 (2006).
6. Hikosaka, O. The habenula: from stress evasion to value-based decision-
making. Nat. Rev. Neurosci. 11, 503–513 (2010).
7. Luo, M., Li, Y. & Zhong, W. Do dorsal raphe 5-HT neurons encode “bene-
ﬁcialness”? Neurobiol. Learn. Mem. 135, 40–49 (2016).
8. Stamatakis, A. M. et al. A unique population of ventral tegmental area neurons
inhibits the lateral habenula to promote reward. Neuron 80, 1039–1053 (2013).
9. Root, D. H. et al. Single rodent mesohabenular axons release glutamate and
GABA. Nat. Neurosci. 17, 1543–1551 (2014).
10. Xie, G. et al. Serotonin modulates glutamatergic transmission to neurons in
the lateral habenula. Sci. Rep. 6, 23798 (2016).
11. Wang, R. Y. & Aghajanian, G. K. Physiological evidence for habenula as major
link between forebrain and midbrain raphe. Science 197, 89–91 (1977).
12. Stern, W. C., Johnson, A., Bronzino, J. D. & Morgane, P. J. Effects of electrical
stimulation of the lateral habenula on single-unit activity of raphe neurons.
Exp. Neurol. 65, 326–342 (1979).
13. Proulx, C. D., Hikosaka, O. & Malinow, R. Reward processing by the lateral
habenula in normal and depressive behaviors. Nat. Neurosci. 17, 1146–1152
(2014).
14. Matsumoto, M. & Hikosaka, O. Representation of negative motivational value
in the primate lateral habenula. Nat. Neurosci. 12, 77–84 (2009).
15. Caldecott-Hazard, S., Mazziotta, J. & Phelps, M. Cerebral correlates of depressed
behavior in rats, visualized using 14C-2-deoxyglucose autoradiography. J.
Neurosci. 8, 1951–1961 (1988).
16. Lisoprawski, A., Herve, D., Blanc, G., Glowinski, J. & Tassin, J. P. Selective acti-
vation of the mesocortico-frontal dopaminergic neurons induced by lesion of
the habenula in the rat. Brain Res. 183, 229–234 (1980).
17. Yang, L. M., Hu, B., Xia, Y. H., Zhang, B. L. & Zhao, H. Lateral habenula lesions
improve the behavioral response in depressed rats via increasing the ser-
otonin level in dorsal raphe nucleus. Behav. Brain Res. 188, 84–90 (2008).
18. Luo, X. F. et al. Lateral habenula as a link between dopaminergic and ser-
otonergic systems contributes to depressive symptoms in Parkinson’s disease.
Brain Res. Bull. 110, 40–46 (2015).
19. Ranft, K. et al. Evidence for structural abnormalities of the human habenular
complex in affective disorders but not in schizophrenia. Psychol. Med. 40,
557–567 (2010).
20. Furman, D. J. & Gotlib, I. H. Habenula responses to potential and actual loss in
major depression: preliminary evidence for lateralized dysfunction. Soc. Cogn.
Affect. Neurosci. 11, 843–851 (2016).
21. Sartorius, A. et al. Remission of major depression under deep brain stimulation
of the lateral habenula in a therapy-refractory patient. Biol. Psychiatry 67,
e9–e11 (2010).
22. Ziegler, D. R., Cullinan, W. E. & Herman, J. P. Distribution of vesicular glutamate
transporter mRNA in rat hypothalamus. J. Comp. Neurol. 448, 217–229 (2002).
23. Brinschwitz, K. et al. Glutamatergic axons from the lateral habenula mainly
terminate on GABAergic neurons of the ventral midbrain. Neuroscience 168,
463–476 (2010).
24. Zhang, L., Hernandez, V. S. & Eiden, L. E. Hypothalamic and Midbrain
Peptidergic-aminergic Pathways Modulate Intrinsic GABAergic Signaling in the
Lateral Habenula: a Study Using In Vivo Juxtacellular Labelling, Retrograde Tra-
cing, IHC and Confocal Microscopy (Society for Neuroscience, San Diego, 2016).
http://www.abstractsonline.com/pp8/index.html-!/4071/presentation/7952
(2016).
25. Atweh, S. F. & Kuhar, M. J. Autoradiographic localization of opiate receptors in
rat brain. II. Brain Stem Brain Res. 129, 1–12 (1977).
26. Pert, C. B., Kuhar, M. J. & Snyder, S. H. Opiate receptor: autoradiographic
localization in rat brain. Proc. Natl Acad. Sci. USA 73, 3729–3733 (1976).
27. Cuello, A. C., Emson, P. C., Paxinos, G. & Jessell, T. Substance P containing and
cholinergic projections from the habenula. Brain Res. 149, 413–429 (1978).
28. Vincent, S. R., McIntosh, C. H., Buchan, A. M. & Brown, J. C. Central somatostatin
systems revealed with monoclonal antibodies. J. Comp. Neurol. 238, 169–186
(1985).
29. Ray, J. P. & Price, J. L. Post-natal changes in the density and distribution of
neurotensin-like immunoreactive ﬁbers in the mediodorsal nucleus of the
thalamus in the rat. J. Comp. Neurol. 292, 269–282 (1990).
30. Hannibal, J. Pituitary adenylate cyclase-activating peptide in the rat central
nervous system: an immunohistochemical and in situ hybridization study. J.
Comp. Neurol. 453, 389–417 (2002).
31. Peyron, C. et al. Neurons containing hypocretin (orexin) project to multiple
neuronal systems. J. Neurosci. 18, 9996–10015 (1998).
32. Buijs, R. M. Intra- and extrahypothalamic vasopressin and oxytocin pathways in
the rat. Pathways to the limbic system, medulla oblongata and spinal cord. Cell
Tissue Res. 192, 423–435 (1978).
33. Hernandez, V. H. et al. Extra-neurohypophyseal axonal projections from indi-
vidual vasopressin-containing magnocellular neurons in rat hypothalamus.
Front. Neuroanat. 9, 130 (2015).
34. Zhang, L., Hernandez, V. S., Vazquez-Juarez, E., Chay, F. K. & Barrio, R. A. Thirst is
associated with suppression of habenula output and active stress coping: is
there a role for a non-canonical vasopressin-glutamate pathway? Front. Neural
Circuits 10, 13 (2016).
35. Smith, Y., Seguela, P. & Parent, A. Distribution of GABA-immunoreactive neu-
rons in the thalamus of the squirrel monkey (Saimiri sciureus). Neuroscience 22,
579–591 (1987).
36. Flanigan M., Aleyasin H., Takahashi A., Golden, S. A. & Russo, S. J. An emerging
role for the lateral habenula in aggressive behavior. Pharmacol. Biochem.
Behav. 162, 79–86 (2017).
37. Iwahori, N. A Golgi study on the habenular nucleus of the cat. J. Comp. Neurol.
72, 319–344 (1977).
38. Zahm, D. S. & Root, D. H. Review of the cytology and connections of the lateral
habenula, an avatar of adaptive behaving. Pharmacol. Biochem. Behav. 162,
3–21 (2017).
39. Shughrue, P. J., Lane, M. V. & Merchenthaler, I. Comparative distribution of
estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J.
Comp. Neurol. 388, 507–525 (1997).
40. Wagner, C. K., Silverman, A. J. & Morrell, J. I. Evidence for estrogen receptor in
cell nuclei and axon terminals within the lateral habenula of the rat: regulation
during pregnancy. J. Comp. Neurol. 392, 330–342 (1998).
41. Li, C. Y. et al. Estradiol suppresses neuronal ﬁring activity and c-Fos expression
in the lateral habenula. Mol. Med Rep. 12, 4410–4414 (2015).
42. Buijs, R. M. et al. Antibodies to small transmitter molecules and peptides:
production and application of antibodies to dopamine, serotonin, GABA,
Zhang et al. Translational Psychiatry  (2018) 8:50 Page 13 of 14
vasopressin, vasoactive intestinal peptide, neuropeptide Y, somatostatin and
substance P. Biomed. Res. 10, 213–221 (1989).
43. van den Pol, A. N. Hypothalamic hypocretin (orexin): robust innervation of the
spinal cord. J. Neurosci. 19, 3171–3182 (1999).
44. Weihe, E. & Eiden, L. E. Chemical neuroanatomy of the vesicular amine
transporters. FASEB J. 14, 2435–2449 (2000).
45. Garcia-Segura, L. M. et al. Aromatase expression by astrocytes after brain injury:
implications for local estrogen formation in brain repair. Neuroscience 89,
567–578 (1999).
46. Pinault, D. Golgi-like labeling of a single neuron recorded extracellularly.
Neurosci. Lett. 170, 255–260 (1994).
47. Pinault, D. A novel single-cell staining procedure performed in vivo under
electrophysiological control: morpho-functional features of juxtacellularly
labeled thalamic cells and other central neurons with biocytin or Neurobiotin.
J. Neurosci. Methods 65, 113–136 (1996).
48. Tukker, J. J. et al. Distinct dendritic arborization and in vivo ﬁring patterns of
parvalbumin-expressing basket cells in the hippocampal area CA3. J. Neurosci.
33, 6809–6825 (2013).
49. Zhang, L. & Hernandez, V. S. Synaptic innervation to rat hippocampus by
vasopressin-immuno-positive ﬁbres from the hypothalamic supraoptic and
paraventricular nuclei. Neuroscience 228, 139–162 (2013).
50. Harris, J. A., Guglielmotti, V. & Bentivoglio, M. Diencephalic asymmetries.
Neurosci. Biobehav. Rev. 20, 637–643 (1996).
51. Engbretson, G. A., Reiner, A. & Brecha, N. Habenular asymmetry and the central
connections of the parietal eye of the lizard. J. Comp. Neurol. 198, 155–165
(1981).
52. Sutherland, R. J. The dorsal diencephalic conduction system: a review of the
anatomy and functions of the habenular complex. Neurosci. Biobehav. Rev. 6,
1–13 (1982).
53. Watanabe, T., Frahm, J. & Michaelis, T. Myelin mapping in the living mouse
brain using manganese-enhanced magnetization transfer MRI. Neuroimage
49, 1200–1204 (2010).
54. Cobbett, P., Yang, Q. Z. & Hatton, G. I. Incidence of dye coupling among
magnocellular paraventricular nucleus neurons in male rats is testosterone
dependent. Brain Res. Bull. 18, 365–370 (1987).
55. Terwel, D., Markerink, M. & Jolles, J. Age-related changes in concentrations of
vasopressin in the central nervous system and plasma of the male Wistar rat.
Mech. Ageing Dev. 65, 127–136 (1992).
56. Macrides, F., Bartke, A. & Dalterio, S. Strange females increase plasma testos-
terone levels in male mice. Science 189, 1104–1106 (1975).
57. Bonilla-Jaime, H., Vazquez-Palacios, G., Arteaga-Silva, M. & Retana-Marquez, S.
Hormonal responses to different sexually related conditions in male rats.
Horm. Behav. 49, 376–382 (2006).
58. Blanchard, R. J., Mast, M. & Blanchard, D. C. Stimulus control of defensive
reactions in the albino rat. J. Comp. Physiol. Psychol. 88, 81–88 (1975).
59. Porsolt, R. D., Bertin, A. & Jalfre, M. Behavioral despair in mice: a primary
screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229, 327–336
(1977).
60. Detke, M. J., Rickels, M. & Lucki, I. Active behaviors in the rat forced swimming
test differentially produced by serotonergic and noradrenergic anti-
depressants. Psychopharmacology 121, 66–72 (1995).
61. Stamatakis, A. M. & Stuber, G. D. Activation of lateral habenula inputs to the
ventral midbrain promotes behavioral avoidance. Nat. Neurosci. 15, 1105–1107
(2012).
62. Baker, P. M. & Mizumori, S. J. Y. Control of behavioral ﬂexibility by the lateral
habenula. Pharmacol. Biochem. Behav. 162, 62–68 (2017).
63. Shabel, S. J., Proulx, C. D., Piriz, J. & Malinow, R. Mood regulation. GABA/
glutamate co-release controls habenula output and is modiﬁed by anti-
depressant treatment. Science 345, 1494–1498 (2014).
64. Gottesfeld, Z., Massari, V. J., Muth, E. A. & Jacobowitz, D. M. Stria medullaris: a
possible pathway containing GABAergic afferents to the lateral habenula.
Brain Res. 130, 184–189 (1977).
65. Naftolin, F. et al. Aromatase immunoreactivity in axon terminals of the ver-
tebrate brain. An immunocytochemical study on quail, rat, monkey and
human tissues. Neuroendocrinology 63, 149–155 (1996).
66. Oberlander, J. G. & Woolley, C. S. 17Beta-estradiol acutely potentiates gluta-
matergic synaptic transmission in the hippocampus through distinct
mechanisms in males and females. J. Neurosci. 36, 2677–2690 (2016).
67. Ledoux, V. A., Smejkalova, T., May, R. M., Cooke, B. M. & Woolley, C. S. Estradiol
facilitates the release of neuropeptide Y to suppress hippocampus-dependent
seizures. J. Neurosci. 29, 1457–1468 (2009).
68. Phoenix, C. H. Organizing action of prenatally administered testosterone
propionate on the tissues mediating mating behavior in the female guinea
pig. Horm. Behav. 55, 566 (2009).
69. Phoenix, C. H., Goy, R. W., Gerall, A. A. & Young, W. C. Organizing action of
prenatally administered testosterone propionate on the tissues mediating
mating behavior in the female guinea pig. Endocrinology 65, 369–382 (1959).
70. Ikeda, T., Matsuki, N. & Yamada, M. K. Estrogen produced in cultured hippo-
campal neurons is a functional regulator of a GABAergic machinery. J. Neu-
rosci. Res. 84, 1771–1777 (2006).
71. Waters, E. M. et al. Estrogen receptor-alpha and beta speciﬁc agonists regulate
expression of synaptic proteins in rat hippocampus. Brain Res. 1290, 1–11
(2009).
72. Wu, M. V. & Tollkuhn, J. Estrogen receptor-alpha is required in GABAergic, but
not glutamatergic, neurons to masculinize behavior. Horm. Behav. 95, 3–12
(2017).
73. May, R. M., Tabatadze, N., Czech, M. M. & Woolley, C. S. Estradiol regulates large
dense core vesicles in the hippocampus of adult female rats. Brain Struct.
Funct. 219, 1947–1954 (2014).
74. Leinwand, S. G. & Chalasani, S. H. From genes to circuits and behaviors:
neuropeptides expand the coding potential of the nervous system. Worm 3,
e27730 (2014).
75. Guemez-Gamboa, A., Xu, L., Meng, D. & Spitzer, N. C. Non-cell-autonomous
mechanism of activity-dependent neurotransmitter switching. Neuron 82,
1004–1016 (2014).
76. Dulcis, D., Jamshidi, P., Leutgeb, S. & Spitzer, N. C. Neurotransmitter switching
in the adult brain regulates behavior. Science 340, 449–453 (2013).
77. Nusbaum, M. P. & Blitz, D. M. Neuropeptide modulation of microcircuits. Curr.
Opin. Neurobiol. 22, 592–601 (2012).
78. Carter, C. S. Oxytocin and Human Evolution. In: Geyer, M. A., Ellenbroek, B. A.,
Marsden, C. A., Barnes, T. R. E., Andersen, S. L. (eds.) Current Topics in Behavioral
Neurosciences, pp. 1–29. Springer, Berlin Heidelberg.
79. Hung, L. W. et al. Gating of social reward by oxytocin in the ventral tegmental
area. Science 357, 1406–1411 (2017).
80. Lammel, S., Lim, B. K. & Malenka, R. C. Reward and aversion in a heterogeneous
midbrain dopamine system. Neuropharmacology 76, 351–359 (2014).
81. Sandi, C. & Haller, J. Stress and the social brain: behavioural effects and neu-
robiological mechanisms. Nat. Rev. Neurosci. 16, 290–304 (2015).
82. Joels, M. & Baram, T. Z. The neuro-symphony of stress. Nat. Rev. Neurosci. 10,
459–466 (2009).
83. McCarthy, M. M. Probing the neural circuits of sex and aggression with pre-
cision genetics: commentary on “Estrogen receptor-alpha is required in
GABAergic but not glutamatergic, neurons to masculinize behavior” by Wu
and Tollkuhn. Horm. Behav. 95, 1–2 (2017).
84. Marder, E., O’Leary, T. & Shruti, S. Neuromodulation of circuits with variable
parameters: single neurons and small circuits reveal principles of state-
dependent and robust neuromodulation. Annu. Rev. Neurosci. 37, 329–346
(2014).
85. Spitzer, N. C. Neurotransmitter switching? No surprise. Neuron 86, 1131–1144
(2015).
86. Paxinos, G. & Watson, C. The Rat Brain in Stereotaxic Coordinates. 6th edn.
(Academic Press, 2007).
Zhang et al. Translational Psychiatry  (2018) 8:50 Page 14 of 14
